Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants.
Fryer HA, Geers D, Gommers L, Zaeck LM, Tan NH, Jones-Freeman B, Goorhuis A, Postma DF, Visser LG, Hogarth PM, Koopmans MPG, GeurtsvanKessel CH, O'Hehir RE, van der Kuy PHM, de Vries RD, van Zelm MC
COVID-19
HIV transcription persists in the brain of virally suppressed people with HIV.
Jamal Eddine J, Angelovich TA, Zhou J, Byrnes SJ, Tumpach C, Saraya N, Chalmers E, Shepherd RA, Tan A, Marinis S, Gorry PR, Estes JD, Brew BJ, Lewin SR, Telwatte S, Roche M, Churchill MJ
HIV + AIDS
Antibody mechanisms of protection against malaria in RTS,S-vaccinated children: a post-hoc serological analysis of phase 2 trial.
Kurtovic L, Feng G, Hysa A, Haghiri A, O'Flaherty K, Wines BD, Santano R, D'Andrea L, Drummer HE, Hogarth PM, Sacarlal J, Fowkes FJI, Simpson JA, Dobaño C, Beeson JG
Malaria
Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action.
Howell J, Combo T, Binks P, Bragg K, Bukulatjpi S, Campbell K, Clark PJ, Carroll M, Davies J, de Santis T, Muller KR, Nguyen B, Olynyk JK, Shackel N, Valery PC, Wigg AJ, George J, Roberts SK
Alcohol and Other Drugs Hepatitis B Hepatitis C
Responsive caregiving: conceptual clarity and the need for indicators.
Black MM, Aboud F, Billah SM, Cerna-Turoff I, Dandona R, Horiuchi S, Lazzerini M, Muñiz M, Strong K, Child Health Accountability Tracking Technical Advisory Group
Maternal, Newborn + Child Health
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C).
Clark PJ, Valery PC, Strasser SI, Weltman M, Thompson A, Levy MT, Leggett B, Zekry A, Rong J, Sinclair M, George J, Sievert W, MacQuillan G, Tse E, Nicoll A, Wade A, Cheng W, Roberts SK
Hepatitis C Alcohol and Other Drugs